Physician
Neurology
Dr. Sotirios A. Parashos, MD
|
|
Give Review
Sotirios Parashos is an expert in the field of Neurology. He went to Aristotle University of Thessaloniki School of Medicine. He received 1 awards: "CMS Meaningful Use Stage 1 Certification". Sotirios A. Parashos has written publications. He has 34 publications published with PubMed. The lastest paper is: 'Ontogenetic development of the locomotor response to levodopa in the rat.' Sotirios Parashos is registered with Medicare and accepts Medicare payments.
Publications
- Effect of creatine monohydrate on clinical progression in patients with Parkinson Disease: a randomized clinical trial.
- Validation of an Ambulatory Capacity Measure in Parkinson Disease: A Construct Derived from the Unified Parkinson's Disease Rating Scale.
- Measuring Disease Progression in Early Parkinson Disease: The National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) Experience.
- Inosine to Increase Serum and Cerebrospinal Fluid Urate in Parkinson Disease: A Randomized Clinical Trial.
- Falls in Parkinson Disease: analysis of a large cross-sectional cohort.
- Mobility, mood and site of care impact health related quality of life in Parkinson's Disease.
- Challenges of multidisciplinary care in Parkinson's Disease.
- Rankin scale as a potential measure of global disability in early Parkinson's Disease.
- Hospitalization in Parkinson Disease: A survey of National Parkinson Foundation Centers.
- Sexual and relationship satisfaction among persons with young-onset Parkinson's Disease.
- Orally disintegrating selegiline in Parkinson patients with dopamine agonist-related adverse effects.
- Assessing cognition in Parkinson Disease: use of the cognitive linguistic quick test.
- Prominent phenotypic variability associated with mutations in Progranulin.
- Falls and injuries resulting from falls among patients with Parkinson's Disease and other parkinsonian syndromes.
- Frequency, reasons, and risk factors of entacapone discontinuation in Parkinson Disease.
- Medical services utilization and prognosis in Parkinson Disease: a population-based study.
- Determinants of the timing of symptomatic treatment in early Parkinson Disease: The National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) Expe...
- Management of the hospitalized patient with Parkinson''s Disease: current state of the field and need for guidelines.
- Piloting the NPF data-driven quality improvement initiative.
- Predictors of cognitive outcomes in early Parkinson Disease patients: The National Institutes of Health Exploratory Trials in Parkinson Disease (NET-PD) experience.
- Morphological, histochemical, and interstitial Pressure changes in the tibialis anterior muscle before and after aortofemoral bypass in patients with peripheral arteri...
- Ontogenetic development of the locomotor response to levodopa in the rat.
- D1 and D2 dopamine receptor-mediated mechanisms and behavioral supersensitivity.
- Attenuation of D-1 antagonist-induced D-1 receptor upregulation by concomitant D-2 receptor blockade.
- [Functional interaction of dopamine receptors and chronic treatment with dopamine-antagonists].
- Supersensitivity to a D-1 dopamine receptor agonist and subsensitivity to a D-2 receptor agonist following chronic D-1 receptor blockade.
- D-1 dopamine receptor changes after striatal quinolinic acid lesion.
- D-1 dopamine agonist administration reduces the threshold for Convulsions produced by pilocarpine.
- Haloperidol- and SCH23390-induced dopaminergic supersensitivities are not additive in the rat.
- Synergy between a selective D1 antagonist and a selective D2 antagonist in the induction of catalepsy.
- Effect of chronic D-1 and/or D-2 dopamine antagonist treatment on SKF 38393-induced non-stereotyped grooming.
- Dopamine D1 receptor modulation of pilocarpine-induced Convulsions.
- Effect of Gi protein ADP-ribosylation induced by pertussis toxin on dopamine-mediated behaviors.
Schools
Aristotle University Of Thessaloniki Faculty Of Medicine
Procedures Preformed
- EEG (Electroencephalogram)
Conditions Treated
- Alzheimer's Disease
- Ataxia
- Brain and Nervous System Cancer (incl. Gliomas, Astrocytoma, Schwannoma, Medulloblastoma, Chordoma)
- Brain Injury
- View All
Doctors Specialties
- Neurology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
University of Minnesota at Fairview -
Aristotle University of Thessaloniki School of Medicine
Drug Facts
| NPI NUMBER | 1104873314 | |
| NPPES Provider LastName | PARASHOS | |
| NPPES Provider FirstName | SOTIRIOS | |
| NPPES Provider ZIPCode | 554352109 | |
| NPPES Provider State | MN | |
| Specialty Description | Neurology | |
| Total Claim Count | 3169.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1104873314 |
| Last Name Of The Provider | PARASHOS |
| First Name Of The Provider | SOTIRIOS |
| View All |
Similar Doctors
|
|
Dr. Richard E. Golden, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mark L. Young, MD |
|
|
Dr. Steven S. Lebow, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Karen A. Hsiao, MD |
|
|
Dr. Xiaoming Dong, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. James Ashe, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Erica A. Colligan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rachel M. Burkard, MD |